- Home
- KRYS vs BEPC Comparison
KRYS vs BEPC Comparison
Compare KRYS & BEPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | KRYS | BEPC |
|---|---|---|
| Founded | 2015 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Electric Utilities: Central |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.8B | 8.0B |
| IPO Year | 2017 | 2019 |
Fundamental Metrics
Financial Performance| Metric | KRYS | BEPC |
|---|---|---|
| Price | $262.33 | $40.86 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 11 | 4 |
| Target Price | ★ $297.60 | $38.50 |
| AVG Volume (30 Days) | 217.1K | ★ 1.4M |
| Earning Date | 05-05-2026 | 05-01-2026 |
| Dividend Yield | N/A | ★ 3.80% |
| EPS Growth | ★ 128.00 | N/A |
| EPS | ★ 6.84 | N/A |
| Revenue | ★ $389,130,000.00 | N/A |
| Revenue This Year | $39.88 | $67.01 |
| Revenue Next Year | $34.38 | $6.14 |
| P/E Ratio | $38.23 | ★ N/A |
| Revenue Growth | ★ 33.94 | N/A |
| 52 Week Low | $123.03 | $23.73 |
| 52 Week High | $298.30 | $45.18 |
Technical Indicators
Market Signals| Indicator | KRYS | BEPC |
|---|---|---|
| Relative Strength Index (RSI) | 55.55 | 52.49 |
| Support Level | $251.93 | $40.62 |
| Resistance Level | $293.60 | $41.52 |
| Average True Range (ATR) | 9.28 | 1.30 |
| MACD | 2.05 | 0.24 |
| Stochastic Oscillator | 90.05 | 79.30 |
Price Performance
Historical ComparisonAbout KRYS Krystal Biotech Inc.
Krystal Biotech Inc is engaged in the healthcare sector in the United States. It is focused on the development of easy-to-use, redosable gene therapies to improve the lives of patients living with debilitating diseases. The company used its proprietary gene therapy platform, STAR-D to develop treatments for rare or orphan dermatological indications caused by the absence of or a mutation in a single gene. It plans to leverage its platform to expand its pipeline to include other dermatological indications in the future. The company has one operating segment, which is the business of developing and commercializing pharmaceutical products.
About BEPC Brookfield Renewable Corporation
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia, and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners LP and Brookfield Renewable Corp.